Statistical Research Associate II

Fred Hutchinson Cancer Research Center & Seattle Cancer Care Alliance
Job Location
Seattle, WA
Job Description

Cures Start Here
At Fred Hutchinson Cancer Research Center, home to three Nobel laureates, interdisciplinary teams of world-renowned scientists seek new and innovative ways to prevent, diagnose and treat cancer, HIV/AIDS and other life-threatening diseases. Fred Hutch's pioneering work in bone marrow transplantation led to the development of immunotherapy, which harnesses the power of the immune system to treat cancer with minimal side effects. An independent, nonprofit research institute based in Seattle, Fred Hutch houses the nation's first and largest cancer prevention research program, as well as the clinical coordinating center of the Women's Health Initiative and the international headquarters of the HIV Vaccine Trials Network.

Careers Start Here .
Fred Hutchinson Cancer Research Center, home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, the Center's five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Hutchinson Center, in collaboration with its clinical and research partners, the University of Washington and Seattle Children's, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Join us and make a difference!

We are seeking a Statistical Research Associate II-III (SRA) for projects within the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO). This NCI funded consortium is integrating somatic and germline genetics with environmental risk factors in order to identify risk factors for colorectal cancer disease susceptibility, and investigate interactions between genetic and envionrmental factors. Analyses will be conducted for several well-characterized studies such as the Women's Health Initiative (WHI) and the Nurses Health Study (NHS), among others. We are seeking a master's-level statistician or biostatistician to support our team. The SRA will have an opportunity to work will several collaborators and there will be several publication opportunities.

The SRA will work with multidisciplinary research teams and directly with investigators to implement data quality control procedures, assist in determining optimum statistical study designs, perform data analyses, and support the development and implementation of statistical methods. In addition, tasks include conducting quality control analyses for GWAS, sequence data, and molecular characteristics data under the guidance of the research team. The person will prepare written summaries and table of results, document statistical analysis, and assist with manuscript preparation.

A master's degree in statistics, biostatistics or epidemiology and at least one year of relevant experience handling large data sets. Experience working with R is required. Experience with epidemiologic studies, as well as statistical and computational methods for the analysis of complex, high-dimensional genotype data, including parallel computing, is a plus. Candidates must be well organized with a proven ability to manage multiple projects at once. Strong oral and written communication skills are important.

We are a VEVRAA Federal Contractor.

To apply for this position, please CLICK HERE

A research duo finds that science and technology graduate students who turn away from academic careers do so because of changes in their own interests.

Students whose classmates are interested in science are more likely to think about a career in science, technology, engineering, and mathematics, a new study says.

CNBC reports that the genetic counseling field is expected to grow as personalized medicine becomes more common.

Gladys Kong writes at Fortune that her STEM background has helped her as a CEO.